Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.010
-0.060 (-5.61%)
Jun 27, 2025, 4:00 PM - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $22.61 million as of June 27, 2025. Its market cap has decreased by -89.18% in one year.
Market Cap
22.61M
Enterprise Value
-67.07M
1-Year Change
-89.18%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $22.61M, a decrease of -93.65%. That is a compound annual growth rate of -89.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 23.95M | -62.96% |
| Dec 31, 2024 | 64.67M | -81.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.87B |
| Johnson & Johnson | 365.58B |
| AbbVie | 330.00B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 275.68B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.25B |
| AstraZeneca | 215.99B |